It was a statement. It wasn't a question.
Through you, Mr. Chair, let me say this. You talked about your tough negotiations with Pfizer. Pfizer, as we know, at the time of these tough negotiations was pitching the federal government to bring in new tax breaks, which included lowering corporate tax and providing tax measures such as manufacturing and processing credits.
Is it safe to say that this government did not take that into consideration? Is it safe to say that we're not going to see this type of quid pro quo in the upcoming budget?